Claudia Gasch Selected Research

Lung Neoplasms (Lung Cancer)

4/2021	MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.
9/2017	Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Gasch Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 10/2016
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2017
2	Lung Neoplasms (Lung Cancer) 04/2021 - 09/2017
2	Adenocarcinoma 04/2021 - 02/2017
1	Breast Neoplasms (Breast Cancer) 03/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021
1	Lymphatic Metastasis 11/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 09/2017
1	ribociclibIBA 03/2022
1	Hormones (Hormone)IBA 03/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	Formaldehyde (Formol)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	AntigensIBA 11/2018
1	Disulfiram (Antabuse)FDA Link 09/2017
1	C.I. Solvent Yellow 56 (DEAB)IBA 09/2017
1	LigandsIBA 04/2017
1	gallium 68 PSMA-11IBA 04/2017

Therapy/Procedure

6	Therapeutics 03/2022 - 01/2017
3	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 11/2016
2	Nephrectomy 10/2019 - 10/2016
1	Castration 01/2022
1	Drug Therapy (Chemotherapy) 04/2021
1	Lymph Node Excision (Lymph Node Dissection) 11/2019
1	Thrombectomy 10/2019
1	Neoadjuvant Therapy 02/2017